Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Marini

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Nucleic Acids Research|July 25, 1990
Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybridsD K Grange, G S Gottesman, M B Lewis, et al.
American Journal of Medical Genetics|January 15, 1993
Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfectaJ C Marini, S Bordenick, G Heavner, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 1, 1990
Failure of surgery and isotretinoin to relieve jaw immobilization in fibrodysplasia ossificans progressiva: report of two casesL J Crofford, J S Brahim, M A Zasloff, et al.
Journal of Animal Science|April 15, 2004
Effect of nitrogen intake on nitrogen recycling and urea transporter abundance in lambsJ C Marini, J D Klein, J M Sands, et al.
Journal of Medical Genetics|August 3, 2006
Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysisW A Cabral, S Milgrom, A D Letocha, et al.
Blood|October 15, 1996
Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host disease across a major histocompatibility complex-haploidentical barrierR M Townsend, C Briggs, J C Marini, et al.
The Journal of Biological Chemistry|December 23, 1999
Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV miceA Forlino, F D Porter, E J Lee, et al.
The Journal of Biological Chemistry|February 5, 1993
Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiologyJ C Marini, M B Lewis, Q Wang, et al.
Bone|October 8, 1999
Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IVN E Vieira, J C Marini, E Hopkins, et al.
Human Mutation|January 1, 1993
A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV probandJ D Filie, B M Orrison, Q Wang, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Nucleic Acids Research|July 25, 1990
Detection of point mutations in type I collagen by RNase digestion of RNA/RNA hybridsD K Grange, G S Gottesman, M B Lewis, et al.
American Journal of Medical Genetics|January 15, 1993
Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfectaJ C Marini, S Bordenick, G Heavner, et al.
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons|February 1, 1990
Failure of surgery and isotretinoin to relieve jaw immobilization in fibrodysplasia ossificans progressiva: report of two casesL J Crofford, J S Brahim, M A Zasloff, et al.
Journal of Animal Science|April 15, 2004
Effect of nitrogen intake on nitrogen recycling and urea transporter abundance in lambsJ C Marini, J D Klein, J M Sands, et al.
Journal of Medical Genetics|August 3, 2006
Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysisW A Cabral, S Milgrom, A D Letocha, et al.
Blood|October 15, 1996
Inhibitory effect of a CD4-CDR3 peptide analog on graft-versus-host disease across a major histocompatibility complex-haploidentical barrierR M Townsend, C Briggs, J C Marini, et al.
The Journal of Biological Chemistry|December 23, 1999
Use of the Cre/lox recombination system to develop a non-lethal knock-in murine model for osteogenesis imperfecta with an alpha1(I) G349C substitution. Variability in phenotype in BrtlIV miceA Forlino, F D Porter, E J Lee, et al.
The Journal of Biological Chemistry|February 5, 1993
Serine for glycine substitutions in type I collagen in two cases of type IV osteogenesis imperfecta (OI). Additional evidence for a regional model of OI pathophysiologyJ C Marini, M B Lewis, Q Wang, et al.
Bone|October 8, 1999
Effect of growth hormone treatment on calcium kinetics in patients with osteogenesis imperfecta type III and IVN E Vieira, J C Marini, E Hopkins, et al.
Human Mutation|January 1, 1993
A de novo G+1-->A mutation at the alpha 2(I) exon 16 splice donor site causes skipping of exon 16 in the cDNA of one allele of an OI type IV probandJ D Filie, B M Orrison, Q Wang, et al.
Pageof 8